Effect of miR-296 on the Apoptosis of Androgen-independent Prostate Cancer Cells

Journal of Reproduction and Contraception

Volumn 20, Issue 1, 2009, Pages 1-9

  CHENG, Pei ^a   LI, Run sheng ^b   LIN, Biao yang ^a,c   WANG, Wei qun ^b   LI, Yu hua ^b   GUO, Yan ^a   LI, Wei ^a  

^a Shanghai Jiao Tong University   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^c Zhejiang California International NanoSystems Institute   (China)

Author keywords

apoptosis; miR 296 5p; prostate cancer cells

Indexed keywords

ANDROGEN; MICRORNA; MIR 296; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL STRAIN LNCAP; GENETIC TRANSFECTION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 71649087944     PISSN: 10017844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-7844(09)60001-8     Document Type: Article

References (11)

1. Kawakami J., Cowan J.E., Elkin E.P., et al. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer 106 8 (2006) 1708-1714
2. Lukka H., Waldron T., Klotz L., et al. Maximal androgen blockade for the treatment of metastatic prostate cancer-a systematic review. Curr Oncol 13 3 (2006) 81-93
3. Kaarb M., Klokk T., and Saatcioglu F. Androgen signaling and its interactions with other signaling pathways in prostate cancer. Bioessays 29 12 (2007) 1227-1238
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 136 2 (2004) 281-297
5. Galardi S., Mercatelli N., Giorda E., et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282 32 (2007) 23716-23724
6. Mott J.L., Kobayashi S., Bronk S.F., et al. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26 42 (2007) 6133-6140
7. Lin B., White J.T., Lu W., et al. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res 65 8 (2005) 3081-3091
8. Cheng A.M., Byrom M.W., Shelton J., et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research 33 4 (2005) 1290-1297
9. Lodygin D., Epanchintsev A., Menssen A., et al. Functional 9. epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65 10 (2005) 4218-4227
10. Yu Y.P., Yu G., Tseng G., et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 67 17 (2007) 8043-8050
11. Navone N.M., Troncoso P., Pisters L.L., et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85 20 (1993) 1657-1669